Mitoxantrone Completed Phase 2 Trials for Androgen-independent Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00661492Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)